A new Nature study shows that the dosage of a single transfer RNA, tRNA1Arg(UCU), acts as a reversible molecular switch ...
The New York Proton Center in East Harlem is the first and only proton therapy center in New York State, but often brings its ...
Researchers at KTH Royal Institute of Technology used multi-omics analysis and machine learning to uncover molecular features ...
Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...
Myriad Genetics ( MYGN) and SOPHiA GENETICS ( SOPH) announced a collaboration with AstraZeneca ( AZN) to advance a new prostate cancer-specific genomic instability score, or PrGIS, for precision ...
The Prostate Cancer Foundation (PCF) today announced the publication of a new consensus framework designed to help clinicians ...
"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...
Daily Mail on MSN
I was hit with terminal prostate cancer at 48 - but thanks to new therapy I'm cancer free
Kevin Mortimer has been described as a 'super responder' to triplet therapy - a method that attacks the cancer with three ...
Kevin Mortimer has been described as a 'super responder' to triplet therapy - a method that attacks the cancer with three ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a collaboration to advance new prostate ...
SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results